Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

This study has been terminated.
(Study was stopped 04.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of 10 patients planned) and CRC patients recruitment was stopped)
Information provided by (Responsible Party):
Wolfgang Hilbe, Medical University Innsbruck Identifier:
First received: September 18, 2009
Last updated: April 28, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)